Jacobs Levy Equity Management, Inc Cytokinetics Inc Transaction History

Jacobs Levy Equity Management, Inc

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 15, 2021	SELL	$18.54 - $35.74 $937,567 - $1.81 Million	-50,570 Closed	0 $0
Q2 2021 Aug 16, 2021	BUY	$19.79 - $26.99 $1 Million - $1.36 Million	50,570 New	50,570 $1 Million
Q4 2020 Feb 16, 2021	SELL	$15.26 - $28.61 $1.73 Million - $3.24 Million	-113,330 Closed	0 $0
Q3 2020 Nov 16, 2020	SELL	$20.58 - $28.96 $2.8 Million - $3.93 Million	-135,877 Reduced 54.52%	113,330 $2.45 Million
Q2 2020 Aug 17, 2020	SELL	$11.15 - $24.64 $5.01 Million - $11.1 Million	-449,545 Reduced 64.34%	249,207 $5.87 Million
Q1 2020 May 15, 2020	BUY	$8.75 - $16.3 $1.64 Million - $3.05 Million	187,022 Added 36.55%	698,752 $8.24 Million
Q4 2019 Feb 14, 2020	BUY	$7.95 - $11.84 $4.07 Million - $6.06 Million	511,730 New	511,730 $5.43 Million
Q2 2019 Aug 13, 2019	SELL	$7.95 - $11.25 $1.75 Million - $2.47 Million	-219,736 Closed	0 $0
Q1 2019 May 14, 2019	BUY	$5.95 - $10.19 $437,325 - $748,965	73,500 Added 50.26%	219,736 $1.78 Million
Q4 2018 Feb 14, 2019	BUY	$5.91 - $9.29 $247,038 - $388,321	41,800 Added 40.02%	146,236 $924,000
Q3 2018 Nov 14, 2018	BUY	$6.4 - $9.85 $102,643 - $157,974	16,038 Added 18.14%	104,436 $1.03 Million
Q2 2018 Aug 14, 2018	BUY	$6.9 - $9.9 $66,226 - $95,020	9,598 Added 12.18%	88,398 $734,000
Q1 2018 May 15, 2018	BUY	$7.2 - $10.05 $567,360 - $791,940	78,800 New	78,800 $567,000
Q3 2017 Nov 14, 2017	SELL	$12.0 - $15.0 $389,568 - $486,960	-32,464 Closed	0 $0
Q2 2017 Nov 09, 2017	BUY	N/A	32,464	32,464 $393,000

409

125M

4.55M

2.42M

Ticker CYTK
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 94,144,096
Market Cap $3.91B
Description
Cytokinetics, Incorporated, a late-stage biopharmaceutical company, focuses on discovering, developing, and commercializing muscle activators and inhibitors as potential treatments for debilitating diseases. The company develops small molecule drug candidates primarily engineered to impact muscle function and contractility. Its drug candidates i...

Get notified when there are updates to the investment portfolio of Jacobs Levy Equity Management, Inc, based on Form 13F filings with the SEC.

Stay updated on Jacobs Levy Equity Management, Inc with notifications on news.